There are at least 10,000 known monogenic diseases. When attempting to cure them, how do clinicians decide which gene-therapy delivery method is best?
One of the best breakdowns on this topic that I've come across. Would love one on the selection factors for cargo (e.g. gene therapy vs. editing vs. ASO, etc.)!
Entos Pharmaceuticals is doing groundbreaking work on expanding the capabilities of LNPs. Really revolutionary. https://entospharma.com/
One of the best breakdowns on this topic that I've come across. Would love one on the selection factors for cargo (e.g. gene therapy vs. editing vs. ASO, etc.)!
Entos Pharmaceuticals is doing groundbreaking work on expanding the capabilities of LNPs. Really revolutionary. https://entospharma.com/